ArticleBioinformation2026
Comparative evaluation of platelet-rich fibrin and collagen membrane for guided bone regeneration in alveolar defects.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alveolar bone defects following tooth loss, trauma, or pathology compromise implant placement and prosthetic rehabilitation, necessitating effective guided bone regeneration strategies. Therefore, it is of interest to compare the clinical and radiographic outcomes of platelet-rich fibrin (PRF) and resorbable collagen membranes in alveolar defect regeneration. Hence, forty patients were randomly allocated into PRF (n=20) and collagen membrane (n=20) groups, both combined with particulate bone graft, with evaluation of healing parameters and CBCT-based bone gain at baseline and 6 months. Both groups demonstrated significant bone regeneration, with slightly greater horizontal gain in the collagen group, while vertical gain and complication rates showed no statistically significant differences. PRF and collagen membranes exhibit comparable regenerative efficacy, with PRF offering additional advantages of autologous origin, cost-effectiveness, and enhanced soft tissue healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.